Sanofi (SNY) Position Raised by Foundation Resource Management Inc.
Foundation Resource Management Inc. raised its stake in shares of Sanofi (NYSE:SNY) by 0.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 374,359 shares of the company’s stock after buying an additional 998 shares during the period. Sanofi comprises about 3.2% of Foundation Resource Management Inc.’s investment portfolio, making the stock its 13th largest position. Foundation Resource Management Inc.’s holdings in Sanofi were worth $17,936,000 at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in the stock. Dodge & Cox acquired a new position in shares of Sanofi during the fourth quarter valued at approximately $2,770,485,000. Fisher Asset Management LLC increased its position in shares of Sanofi by 8.1% in the second quarter. Fisher Asset Management LLC now owns 13,638,458 shares of the company’s stock valued at $653,419,000 after buying an additional 1,022,953 shares during the last quarter. Bank of America Corp DE increased its position in shares of Sanofi by 8.2% in the first quarter. Bank of America Corp DE now owns 7,531,334 shares of the company’s stock valued at $340,792,000 after buying an additional 572,652 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of Sanofi by 22.2% in the first quarter. Wells Fargo & Company MN now owns 4,492,719 shares of the company’s stock valued at $203,296,000 after buying an additional 815,820 shares during the last quarter. Finally, Brandes Investment Partners LP increased its position in shares of Sanofi by 3.0% in the first quarter. Brandes Investment Partners LP now owns 3,490,226 shares of the company’s stock valued at $157,933,000 after buying an additional 102,511 shares during the last quarter. Institutional investors and hedge funds own 9.84% of the company’s stock.
Shares of Sanofi (NYSE:SNY) traded down 1.10% during midday trading on Tuesday, reaching $47.65. The company’s stock had a trading volume of 788,228 shares. The stock’s 50 day moving average price is $48.89 and its 200 day moving average price is $44.55. The firm has a market cap of $120.34 billion, a price-to-earnings ratio of 11.52 and a beta of 0.89. Sanofi has a one year low of $36.81 and a one year high of $50.24.
Sanofi (NYSE:SNY) last released its earnings results on Friday, April 28th. The company reported $0.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.03. Sanofi had a net margin of 26.55% and a return on equity of 25.89%. The business had revenue of $8.65 billion for the quarter, compared to analyst estimates of $8.40 billion. The firm’s revenue for the quarter was up 1.2% compared to the same quarter last year. Analysts predict that Sanofi will post $3.15 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Sanofi (SNY) Position Raised by Foundation Resource Management Inc.” was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/sanofi-sny-position-raised-by-foundation-resource-management-inc/1449815.html.
SNY has been the topic of several research analyst reports. J P Morgan Chase & Co upgraded Sanofi from an “underperform” rating to a “neutral” rating in a research report on Tuesday, April 11th. BidaskClub downgraded Sanofi from a “buy” rating to a “hold” rating in a research report on Friday, June 9th. Zacks Investment Research upgraded Sanofi from a “hold” rating to a “buy” rating and set a $55.00 target price on the stock in a research report on Friday, June 2nd. Berenberg Bank downgraded Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Finally, HSBC Holdings plc downgraded Sanofi from a “hold” rating to a “reduce” rating in a research report on Friday, April 7th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $67.67.
Sanofi Company Profile
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
Want to see what other hedge funds are holding SNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sanofi (NYSE:SNY).
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with Analyst Ratings Network's FREE daily email newsletter.